| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 138.26B | 132.05B | 125.94B | 117.66B | 117.30B |
| Gross Profit | 15.80B | 15.04B | 13.60B | 13.21B | 12.11B |
| EBITDA | 7.49B | 6.50B | 4.97B | 5.15B | 4.88B |
| Net Income | 3.72B | 3.40B | 3.04B | 3.22B | 2.45B |
Balance Sheet | |||||
| Total Assets | 157.17B | 150.87B | 128.06B | 114.63B | 121.60B |
| Cash, Cash Equivalents and Short-Term Investments | 25.84B | 24.07B | 20.32B | 12.97B | 25.44B |
| Total Debt | 36.41B | 34.85B | 18.64B | 16.19B | 20.19B |
| Total Liabilities | 106.71B | 102.07B | 82.33B | 70.76B | 80.01B |
| Stockholders Equity | 50.36B | 48.79B | 45.72B | 43.86B | 41.58B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | -11.88B | 5.64B | -7.81B | 1.96B |
| Operating Cash Flow | 0.00 | -9.99B | 6.33B | -6.19B | 4.17B |
| Investing Cash Flow | -1.35B | -1.44B | -508.00M | -1.77B | -1.18B |
| Financing Cash Flow | 207.00M | 14.91B | 1.45B | -4.56B | -846.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥50.73B | 6.41 | ― | 3.97% | 2.85% | 317.62% | |
77 Outperform | ¥41.54B | 6.66 | ― | 3.88% | 4.11% | 28.37% | |
75 Outperform | ¥53.72B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
73 Outperform | ¥50.28B | 7.92 | ― | 1.96% | 2.55% | -14.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥73.71B | 26.09 | ― | 0.79% | -8.53% | -83.61% | |
60 Neutral | ¥61.24B | 19.35 | ― | 1.57% | 11.01% | 231.83% |